Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Management of castrate resistant prostate cancer-recent advances and optimal sequence of treatments.

Management of castrate resistant prostate cancer-recent advances and optimal sequence of treatments. Curr Urol Rep. 2013 Jun; 14(3):174-83.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.